OB-RHSCT-101

• Research type

  Research Study

• Full title

  Efficacy of Personalised Irradiation with Rhenium-Skin Cancer Therapy (SCT) for the treatment of non-melanoma skin cancer; a phase IV multi-centre, international, open label, single arm study.

• IRAS ID

  308557

• Contact name

  Gerhard Dahlhoff

• Contact email

  gerhard.dahlhoff@oncobeta.com

• Sponsor organisation

  Oncobeta Therapeutics Pty Ltd

• Clinicaltrials.gov Identifier

  NCT05135052

• Clinicaltrials.gov Identifier

  HD 1286123-1, EC Certificate

• Duration of Study in the UK

  2 years, 0 months, 1 days

• Research summary

  This research study is being done to test the effectiveness and safety of Rhenium-SCT in the treatment of on-melanoma skin cancer (NMSC). This research study is also looking at: changes in the quality of life for participants before treatment and at 6 months and 12 months post treatment, the comfort of treatment and the cosmetic outcome for participants.

• REC name

  Yorkshire & The Humber - Bradford Leeds Research Ethics Committee

• REC reference

  22/YH/0067

• Date of REC Opinion

  7 Apr 2022

• REC opinion

  Further Information Favourable Opinion